Pulsenmore Forms Key Partnership with Ouma Health to Expand US Remote Prenatal Care
Summary
Pulsenmore has formed a strategic partnership with Ouma Health, a leading virtual maternity care provider in the U.S. This collaboration will integrate Pulsenmore's FDA-authorized home ultrasound platform into Ouma Health's virtual care model, expanding access to remote prenatal monitoring. For Pulsenmore, this represents a significant opportunity to penetrate the U.S. maternal health market, building on its recent FDA approval. The partnership aims to address critical access gaps in maternal care, particularly in underserved communities.
At the time of this announcement, PLSM was trading at $4.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $22.2M. The 52-week trading range was $3.00 to $10.28. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.